Peripheral Artery Disease Market
size is projected to record a 7.80% CAGR to influence income earning in the
market to USD 4,630.0 Million by 2030.
Increased global prevalence of
artery diseases has fuelled the demand for peripheral
artery disease market. Market
Research Future (MRFR) in its latest report reveals that the global peripheral
artery diseases market will exhibit a healthy CAGR during the forecast period.
Atherosclerosis in the peripheral
arteries remain the leading cause of peripheral artery disease. Atherosclerosis
in associated with hardening of plaque that trigger clot formation in arteries,
leading to their blockage.
Global demand for peripheral artery
disease treatment has grown substantially in recent years. Availability of
superior treatment and therapeutics for peripheral artery disease has reflected
favourably on the market. Many market players have ramped up investment in
R&D program to develop innovative treatment solution. The market is reaping
benefits for increased R&D in healthcare. Data released by European
Federation of Pharmaceutical Industries and Association reveals that in 2016
R&D investments in the Pharmaceutical Industry reached EUR 35000 Mn. The Centres for Disease Control and
Prevention noted that in the U.S. per capita national health spending stood at
USD 9,990 and the overall national health spending surpassed USD 3 trillion.
High healthcare spending in advanced countries is viewed as key market driver.
The global peripheral artery disease
market is also being influenced by factors such as increased occurrence of
arterial diseases and associated complications, increase healthcare
penetration, rising level of awareness, improve reimbursement policies and
increasing geriatric population. However, formidable challenges lie ahead.
Factors such as influx of fake drug, high risk oh infection and severe
side-effects associated with treatment options somewhat derail the market
growth.
Request Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/1540
Global Peripheral Artery Disease Market: Segmental Analysis
The segment analysis of the market
has been conducted based on devices, drugs, and types of diseases.
On the basis of devices, the market
has been segmented into atherectomy devices, angioplasty balloon catheters,
stents and others. The stents segment is further sub-segmented into
self-expandable and balloon-expandable. The atherectomy devices segment is
further sub-segmented into orbital, directional, rotational and laser.
On the basis drugs, the market has
been segmented into glucose regulating drug, lipid-lowering drugs and other.
Based of types of diseases, the market has been segmented into lymphedema,
blood clotting disorders, atherosclerosis and other.
Global Peripheral Artery Disease Market: Competition Analysis
B. Braun Melsungen AG,
Boston Scientific Corporation, TERUMO CORPORATION, Sanofi S.A., AstraZeneca
Plc., Bristol-Myers Squibb Company, Merck & Co., Inc., Symic Bio, Inc.,
CardioVascular BioTherapeutics, Inc., Medtronic., KONINKLIJKE PHILIPS N.V,
Proteon Therapeutics, Inc., Smith & Nephew plc, Bayer HealthCare
Pharmaceuticals, Zimmer Biomet Holdings, Inc., Abbott, Dickinson and Company
(BD), Cook Medical, Becton, Johnson & Johnson Services, Inc., Alcon
Laboratories, Inc., Angioscore, Inc., Betagenon AB, TheraVasc Inc., Aspen Surgical
Products, Inc., Stryker Corporation,
AnGes, Inc. and Cordis are among the top-notch companies operating in
the market.
Global Peripheral Artery Disease Market: Regional Analysis
Regions covered in the
report include Europe, the Middle East & Africa (MEA), Asia Pacific (APAC),
and North America. A vast and robust healthcare sector in the U.S. makes North
America a major market for peripheral artery disease treatment. Extensive
healthcare penetration coupled with sound medical expertise and high medical
healthcare expenditure. Additionally, rising patient pool is a key driver of
the market in North America. Development of peripheral artery diseases is also
linked with obesity and diabetes. The APAC peripheral artery disease market is
also anticipated to witness a healthy growth over the next several years.
Increased focus on improving the care quality propelling the market growth in
the region. During the forecast period, the market in the region is expected to
exhibit the highest growth.
Browse Detailed TOC
with COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/peripheral-artery-disease-market-1540
About Market
Research Future:
At Market Research
Future (MRFR), we enable our customers to unravel the complexity of various
industries through our Cooked Research Report (CRR), Half-Cooked Research
Reports (HCRR), & Consulting Services. MRFR team have supreme objective to
provide the optimum quality market research and intelligence services to our
clients.
Contact us:
Market Research
Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,
5Th Floor,
New York, New York
10013
United States of
America
+1 628 258 0071
Email:
sales@marketresearchfuture.com
,
Comments
Post a Comment